Bromeact is a dietary supplement that contains the enzyme bromelain which is derived from pineapple.
Bromelain contributes to the normal function of the immune system.
- increases the production of prostaglandins with anti-inflammatory action.
- inhibits the transformation of kininogen into kinin.
- stimulates PGE1 (selectively inhibits the accumulation of platelets and consequently blood coagulation).
- develops a fibrinolytic action in interaction with the lipoxygenase through the plasminogen (increases plasmin creation), which breaks down the fibrin clots (fibrinolysis), delaying at the same time the creation of a local swelling.
- selectively inhibits 5-lipoxygenase, and blocks the synthesis of leukotrienes B4 (receptor of chronic inflammation phase) along with the leukotrienes C4, D4, E4 (receptors of acute inflammation phase).
- does not reverse the synthesis of gastroprotective prostaglandins as it happens with the NSAIDS [non steroidal anti-inflammatory drugs].
- reverses the shift of the polymorphonuclear leukocytes and the release of proteolytic enzynes.
- acts in the lymphatic system due to its ability to increase the proteolytic action of macrophages.
- decreases the catabolism of catecholamines (adrenalin) on a vascular level and contributes to the ability of capillaries to contract; as a result it reduces swelling and pain.
Notification number of the National Organization for Medicines (EOF): 28343 / 8-04-2013.
The notification number in the National Organization for Medicines (EOF) does not serve as an authorization for marketing by the EOF.